Standard BioTools Inc (LAB)
2.48
-0.08
(-3.12%)
USD |
NASDAQ |
May 31, 16:00
2.475
0.00 (0.00%)
After-Hours: 20:00
Standard BioTools Accounts Receivable (Quarterly): 36.01M for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 36.01M |
December 31, 2023 | 19.66M |
September 30, 2023 | 16.56M |
June 30, 2023 | 15.12M |
March 31, 2023 | 14.50M |
December 31, 2022 | 17.28M |
September 30, 2022 | 17.29M |
June 30, 2022 | 10.94M |
March 31, 2022 | 15.42M |
December 31, 2021 | 18.32M |
September 30, 2021 | 13.73M |
June 30, 2021 | 15.67M |
March 31, 2021 | 15.41M |
December 31, 2020 | 25.42M |
September 30, 2020 | 17.61M |
June 30, 2020 | 9.983M |
March 31, 2020 | 14.41M |
December 31, 2019 | 18.98M |
September 30, 2019 | 14.01M |
June 30, 2019 | 19.26M |
March 31, 2019 | 19.31M |
December 31, 2018 | 16.65M |
September 30, 2018 | 18.38M |
June 30, 2018 | 16.87M |
March 31, 2018 | 16.27M |
Date | Value |
---|---|
December 31, 2017 | 15.05M |
September 30, 2017 | 13.73M |
June 30, 2017 | 13.66M |
March 31, 2017 | 14.39M |
December 31, 2016 | 14.61M |
September 30, 2016 | 12.84M |
June 30, 2016 | 18.88M |
March 31, 2016 | 19.64M |
December 31, 2015 | 25.46M |
September 30, 2015 | 26.25M |
June 30, 2015 | 21.79M |
March 31, 2015 | 19.58M |
December 31, 2014 | 22.38M |
September 30, 2014 | 16.92M |
June 30, 2014 | 13.33M |
March 31, 2014 | 18.79M |
December 31, 2013 | 10.55M |
September 30, 2013 | 12.41M |
June 30, 2013 | 10.84M |
March 31, 2013 | 10.06M |
December 31, 2012 | 12.90M |
September 30, 2012 | 10.65M |
June 30, 2012 | 9.612M |
March 31, 2012 | 9.764M |
December 31, 2011 | 9.253M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
9.983M
Minimum
Jun 2020
36.01M
Maximum
Mar 2024
17.28M
Average
16.11M
Median
Accounts Receivable (Quarterly) Benchmarks
Bruker Corp | 475.40M |
Azenta Inc | 154.67M |
Harvard Bioscience Inc | 15.31M |
Bionano Genomics Inc | 8.313M |
Akoya Biosciences Inc | 13.47M |